期刊文献+

Influence of Y151 F mutation in loop B on the agonist potency in insect nicotinic acetylcholine receptor

Influence of Y151 F mutation in loop B on the agonist potency in insect nicotinic acetylcholine receptor
原文传递
导出
摘要 Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels, which mediate fast cholinergic synaptic transmission in insect and vertebrate nervous systems. The nAChR agonist-binding site is present at the interface of adjacent subunits and is formed by loops A-C present in α subunits together with loops D-F present in either non-α subunits or homomer-forming α subunits. Although Y151 in loop B has been identified as important in agonist binding, various residues at the 151-site are found among vertebrate and invertebrate nAChR α subunits, such as F 151. In Xenopus oocytes expressing Nlα1 or Nlα1^Y151F plus rat β2, Y151F mutation was found to significantly change the rate of receptor desensitization and altered the pharmacological properties of acetylcholine, but not imidacloprid, including the decrease Of Imax, the increase of EC50 (the concentration causing 50% of the maximum response) and the fast time-constant of decay (τf). By comparisons of residue structure, the hydroxyl group in the side chain of Y151 was thought to be important in the interaction between Nlα1/β2 nAChRs and acetylcholine, and the phenyl group to be important between Nlα1/β2 nAChRs and imidacloprid. Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels, which mediate fast cholinergic synaptic transmission in insect and vertebrate nervous systems. The nAChR agonist-binding site is present at the interface of adjacent subunits and is formed by loops A-C present in α subunits together with loops D-F present in either non-α subunits or homomer-forming α subunits. Although Y151 in loop B has been identified as important in agonist binding, various residues at the 151-site are found among vertebrate and invertebrate nAChR α subunits, such as F 151. In Xenopus oocytes expressing Nlα1 or Nlα1^Y151F plus rat β2, Y151F mutation was found to significantly change the rate of receptor desensitization and altered the pharmacological properties of acetylcholine, but not imidacloprid, including the decrease Of Imax, the increase of EC50 (the concentration causing 50% of the maximum response) and the fast time-constant of decay (τf). By comparisons of residue structure, the hydroxyl group in the side chain of Y151 was thought to be important in the interaction between Nlα1/β2 nAChRs and acetylcholine, and the phenyl group to be important between Nlα1/β2 nAChRs and imidacloprid.
出处 《Insect Science》 SCIE CAS CSCD 2009年第5期365-369,共5页 昆虫科学(英文版)
基金 Acknowledgments This work was supported by the Program for New Century Excellent Talents in University (06-0494), National Natural Science Foundation of China Program Grant (30700528) and Special Fund for Basic Expenditure for Scientific & Research of Central Non-profit Scientific Research Institutions (2007RG016).
关键词 ACETYLCHOLINE agonist potency IMIDACLOPRID nicotinic acetylcholine receptor Nilaparvata lugens Xenopus oocytes acetylcholine, agonist potency, imidacloprid, nicotinic acetylcholine receptor, Nilaparvata lugens, Xenopus oocytes
  • 相关文献

参考文献12

  • 1Arias, H.R. (1997) Topology of ligand binding sites on the nicotinic acetylcholine receptor. Brain Research Review, 25,133- 191.
  • 2Arias, H.R. (2000) Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors. Neurochemistry International, 36, 595-645.
  • 3Boorman, J.P.B., Groot-Kormelink, EJ. and Sivilotti, L.G. (2000) Stoichiometry of human recombinant neuronal nicotinic receptors containing the β3 subunit expressed in Xenopus oocytes. Journal of Physiology, 529, 565-577.
  • 4Brejc, K., Dijk, W.J., Klaassen, R.V., Schuurmans, M., Oost, J., Smit, A.B. and Sixma, T.K. (2001) Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature, 411,269-276.
  • 5Corringer, P.J., Le-Novere, N. and Changeux, J.P. (2000) Nicotinic receptors at the amino acid level. AnnualReview of Pharmacology and Toxicology, 40, 431-458.
  • 6Gotti, C. and Clementi, E (2004) Neuronal nicotinic receptors: from structure to pathology. Progress in Neurobiology, 74, 363-396.
  • 7Grutter, T. and Changeux, J.P. (2001) Nicotinic receptors in wonderland. Trends in Biochemical Sciences, 26, 459-463.
  • 8Liu, Z.W., Williamson, M.S., Lansdell, S.J., Denholm, I., Han, Z.J. and Millar, N.S. (2005) A nicotinic acetylcholine receptor mutation conferring target-site resistance to imidacloprid in Nilaparvata lugens (brown planthopper). The Proceedings of the National Academy of Sciences of the United States of America, 102, 8420-8425.
  • 9Liu, Z.W., Williamson, M.S., Lansdell, S.J., Han, Z.J., Denholm, I. and Millar, N.S. (2006) A nicotinic acetylcholine receptor mutation (Y151S) causes reduced agonist potency to a range of neonicotinoids. Journal of Neurochemistry, 99, 1273-1281.
  • 10Qrtells, M.O. and Lunt, G.G. (1995) Evolutionary history of the ligand-gated ion-channel superfamily of receptors. Trends in Biochemical Sciences, 18, 121-127.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部